EAM
MDNA

Empery Asset Management’s Medicenna Therapeutics Corp. Common Shares MDNA Stock Holding History

Empery Asset Management’s Portfolio MDNA Stock Details MDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$489K Buy
+589,316
New +$665K 2.91% 10

Other funds holding MDNA

ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
GPCM
Granite Point Capital Management Boston, Massachusetts $4.9M AUM 38.41% 1-Year Est. Return
SPC
Sigma Planning Corp Ann Arbor, Michigan $3.6B AUM 24.57% 1-Year Est. Return
ACM
ACT Capital Management Wayne, Pennsylvania $153M AUM
MS
Maven Securities St Helier, Jersey $5.2B AUM 44.01% 1-Year Est. Return

Empery Asset Management's MDNA Position: Q3 2022 in Review

Empery Asset Management opened a new position in Medicenna Therapeutics Corp. Common Shares (MDNA) in Q3 2022: 589,316 shares worth $489K. The stake represents 2.91% of the portfolio and ranks #10 among its holdings.

28 funds tracked by Wall St. Rank hold MDNA as of Q3 2022.

  • Empery Asset Management held 589,316 shares of Medicenna Therapeutics Corp. Common Shares worth $489K as of Q3 2022.
  • Medicenna Therapeutics Corp. Common Shares was a new Empery Asset Management position in Q3 2022.
  • Medicenna Therapeutics Corp. Common Shares made up 2.91% of Empery Asset Management's portfolio in Q3 2022, its #10 holding.
  • 28 funds tracked by Wall St. Rank held Medicenna Therapeutics Corp. Common Shares as of Q3 2022.

Based on Empery Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.